Walker v. Pharmaceutical Research & Manufacturers of America

461 F. Supp. 2d 52, 2006 U.S. Dist. LEXIS 82854, 2006 WL 3302681
CourtDistrict Court, District of Columbia
DecidedNovember 15, 2006
DocketCivil Action 04-1991 (RMU)
StatusPublished
Cited by24 cases

This text of 461 F. Supp. 2d 52 (Walker v. Pharmaceutical Research & Manufacturers of America) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walker v. Pharmaceutical Research & Manufacturers of America, 461 F. Supp. 2d 52, 2006 U.S. Dist. LEXIS 82854, 2006 WL 3302681 (D.D.C. 2006).

Opinion

MEMORANDUM OPINION

URBINA, District Judge.

Denying the Plaintiff’s Motion to Alter or Amend Judgment

I. INTRODUCTION

This matter comes before the court on the plaintiffs motion to alter or amend judgment pursuant to Federal Rule of Civil Procedure 59(e). The plaintiff asks the court to vacate its July 17, 2006 order granting summary judgment in favor of the defendants. She argues that the court erroneously ruled that the plaintiffs Employment Retirement Income Security Act (“ERISA”), 29 U.S.C. §§ 1001 et seq., claims are time-barred. 1 Because the plaintiff had notice of her claims on or before September 2001 and because the plaintiff fails to demonstrate fraudulent concealment by the defendants, the court denies the plaintiffs motion to alter or amend.

II. BACKGROUND

A. Factual Background

The plaintiff, an attorney, was a full-time employee of defendant Pharmaceutical Research and Manufacturers of America 2 (“PhRMA”) in various professional capacities from 1977 to 1988. Mem. Op. (July 17, 2006) (“Mem.Op.”) at 2. Following the birth of her second child in 1988, the plaintiff requested but was denied a part-time work arrangement because PhRMA’s then-president “did not believe in part-time professionals.” Id. Instead, PhRMA’s General Counsel, Bruce Brennan, suggested that the plaintiff serve as an independent contractor. Id. The plaintiff accepted this arrangement and signed an independent contractor agreement on March 24, 1988. 3 Id. At the expiration of that agreement, the plaintiff and PhRMA signed identically worded agreements every year until 2001. Id. at 3. The final agreement, signed on September 12, 2001, notified the plaintiff that PhRMA did not intend to continue their relationship following the expiration of the agreement on June 30, 2002. Id.

The independent contractor agreements signed by the plaintiff each year stated that the plaintiff “shall be engaged as an independent contractor, not as an employee, and shall not be entitled to participate in any of [PhRMA’s] employee benefit plans.” Id. at 2-3. The plaintiff alleges that she signed the independent contractor agreements based on the belief that part-time employees, like independent contractors, were ineligible for employee benefits. Id. at 2. In other words, the plaintiff alleges that she “had no reason” to challenge her classification as an independent contractor rather than as a part-time employee because she believed the “terms and conditions of her employment” were the same as those of part-time employees. PL’s Mem. in Supp. of Mot. to Alter or Amend J. (“PL’s Mot.”) at 5.

*55 Sometime between 1991 and 1994, PhRMA reinterpreted its retirement plan to make part-time employees eligible for certain retirement benefits. PL’s Mot. at 5. The plaintiff alleges that the defendants violated ERISA because they failed to notify independent contractors of the changes affecting part-time employees. Id. at 5,13,16.

B. Procedural Background

The plaintiff filed her original complaint on November 11, 2004 and she amended her complaint in August 2005. Although difficult to parse, the complaint appears to assert the following claims arising under ERISA 4 : (1) that the plaintiff is entitled to benefits under 29 U.S.C. § 1132(a)(1)(B) (“ERISA § 502”); (2) that the defendants interfered with her rights to retirement benefits by improperly classifying her as an independent contractor, in violation of 29 U.S.C. § 1140 (“ERISA § 510”); and (3) that the defendants breached their fiduciary duties by either failing to notify the plaintiff that part-time employees were eligible to receive benefits, or by classifying her as an independent contractor, rather than as a part-time employee, in violation of 29 U.S.C. § 1104 (“ERISA § 404”).

The defendants 5 moved for summary judgment in October 2005 on the grounds that the plaintiffs claims were barred by the statute of limitations and were preempted by common law. The court granted the defendants’ motion on July 17, 2006, and the plaintiff filed a motion to alter or amend the judgment on July 31, 2006. The court now turns to the plaintiffs motion.

III. ANALYSIS

A. Legal Standard for a Rule 59(e) Motion

Federal Rule of Civil Procedure 59(e) provides that a motion to alter or amend a judgment must be filed within 10 days of the entry of the judgment at issue. Fed.R.Civ.P. 59(e); see also Mashpee Wampanoag Tribal Council, Inc. v. Norton, 336 F.3d 1094, 1098 (D.C.Cir.2003) (stating that a Rule 59(e) motion “must be filed within 10 days of the challenged order, not including weekends, certain specified national holidays (including Christmas Day and New Year’s Day), or any other day appointed as a holiday by the President”). While the court has considerable discretion in ruling on a Rule 59(e) motion, the reconsideration and amendment of a previous order is an unusual measure. Firestone v. Firestone, 76 F.3d 1205, 1208 (D.C.Cir.1996) (per curiam); McDowell v. Calderon, 197 F.3d 1253, 1255 (9th Cir.1999). Rule 59(e) motions “need not be granted unless the district court finds that there is an intervening change of controlling law, the availability of new evidence, or the need to correct a clear legal error or prevent manifest injustice.” Ciralsky v. Cent. Intelligence Agency, 355 F.3d 661, 671 (D.C.Cir.2004) (quoting Firestone, 76 F.3d at 1208). Moreover, “[a] Rule 59(e) motion to reconsider is not simply an opportunity to reargue facts and theories upon which a court has already' ruled,” *56 New York v. United States, 880 F.Supp. 37, 38 (D.D.C.1995), or a vehicle for presenting theories or arguments that could have been advanced earlier. Kattan v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jones v. District of Columbia
District of Columbia, 2021
Beach Tv Properties Inc. v. Soloman
District of Columbia, 2020
Bloche v. Department of Defense
District of Columbia, 2019
Miller Legal LLP v. Miller
District of Columbia, 2019
Sierra v. Hayden
254 F. Supp. 3d 230 (District of Columbia, 2017)
Bronner v. Duggan
249 F. Supp. 3d 27 (District of Columbia, 2017)
Sherrod v. McHugh
District of Columbia, 2017
United States Ex Rel. Morsell v. Symantec Corp.
130 F. Supp. 3d 106 (District of Columbia, 2015)
Campbell v. District of Columbia
126 F. Supp. 3d 141 (District of Columbia, 2015)
Zuza v. Office of the High Representaitve
107 F. Supp. 3d 90 (District of Columbia, 2015)
Floyd v. Lee
85 F. Supp. 3d 482 (District of Columbia, 2015)
Dorsett v. County of Nassau
800 F. Supp. 2d 453 (E.D. New York, 2011)
Harris v. Koenig
722 F. Supp. 2d 44 (District of Columbia, 2010)
Walker v. Pharmaceutical Research & Manufacturers of America
569 F. Supp. 2d 209 (District of Columbia, 2008)
Alston v. District of Columbia
561 F. Supp. 2d 29 (District of Columbia, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
461 F. Supp. 2d 52, 2006 U.S. Dist. LEXIS 82854, 2006 WL 3302681, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walker-v-pharmaceutical-research-manufacturers-of-america-dcd-2006.